Substrate Reduction Therapy (SRT) Innovations in the US Fabry...

added blog Health

2026-10-22 13:13:39 - Translate -

Substrate Reduction Therapy (SRT) Innovations in the US Fabry Disease Market

Developing oral substrate reduction therapies (SRT) to inhibit upstream glycosphingolipid biosynthesis is expanding non-enzyme treatment options within the US Fabry Disease Market. Substrate reduction therapies utilize small-molecule inhibitors to target glucosylceramide synthase, the key enzyme responsible for initiating glycosphingolipid synthesis. Decreasing the rate of cellular...

0 Comments 0 Shares 187 Views 0 Reviews